Pharmacokinetic-Pharmacodynamic modelling of intracellular Mycobacterium tuberculosis growth and kill rates is predictive of clinical treatment duration-Reference-Cited by-同舟云学术

Pharmacokinetic-Pharmacodynamic modelling of intracellular Mycobacterium tuberculosis growth and kill rates is predictive of clinical treatment duration

Published:2017-03-29 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Aljayyoussi Ghaith,Jenkins Victoria A.,Sharma Raman,Ardrey Alison,Donnellan Samantha,Ward Stephen A.,Biagini Giancarlo A.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-017-00529-6.pdf

Reference67 articles.

1. WHO. Global Tuberculosis Report 2015 (World Health Organisation, 2015).

2. Gumbo, T., Lenaerts, A. J., Hanna, D., Romero, K. & Nuermberger, E. Nonclinical models for antituberculosis drug development: a landscape analysis. The Journal of infectious diseases 211 Suppl 3, S83–S95, 10.1093/infdis/jiv183 (2015).

3. Muliaditan, M., Davies, G. R., Simonsson, U. S., Gillespie, S. H. & Della Pasqua, O. The implications of model-informed drug discovery and development for tuberculosis. Drug Discov Today, doi: 10.1016/j.drudis.2016.09.004 (2016).

4. Hu, Y., Coates, A. R. & Mitchison, D. A. Sterilizing activities of fluoroquinolones against rifampin-tolerant populations of Mycobacterium tuberculosis. Antimicrobial agents and chemotherapy 47, 653–657 (2003).

5. Nuermberger, E. L. et al. Moxifloxacin-containing regimen greatly reduces time to culture conversion in murine tuberculosis. American journal of respiratory and critical care medicine 169, 421–426, doi: 10.1164/rccm.200310-1380OC (2004).

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Breaking barriers: The potential of nanosystems in antituberculosis therapy;Bioactive Materials;2024-09

2. Application of MIDD to accelerate the development of anti-infectives: Current status and future perspectives;Advanced Drug Delivery Reviews;2024-09

3. Dual β-lactams for the treatment of Mycobacterium abscessus: a review of the evidence and a call to act against an antibiotic nightmare;Journal of Antimicrobial Chemotherapy;2024-08-16

4. Host cell environments and antibiotic efficacy in tuberculosis;Trends in Microbiology;2023-09

5. Plasmodium falciparum-infected erythrocyte co-culture with the monocyte cell line THP-1 does not trigger production of soluble factors reducing brain microvascular barrier function;PLOS ONE;2023-05-04